You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back


Priorix is indicated for the active immunisation of children from the age of 9 months or older, adolescents and adults against measles, mumps and rubella. [1]
For use in children between 9 to 12 months of age please refer to the Summary of Product Characteristics (SPC). [1]


  1. Priorix Summary of Product Characteristics. Available from: Last accessed - January 2017

Priorix is a registered trademark of the GlaxoSmithKline group of companies